Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas.
Although progress has been made in our understanding of the pathogenesis of the disease …

Importance Graves disease is the most common cause of persistent hyperthyroidism in
adults. Approximately 3% of women and 0.5% of men will develop Graves disease during …

Context: Several treatment options are available for Graves' disease (GD), including
antithyroid drugs (ATDs), radioactive iodine (RAI), and thyroidectomy. Objective: The primary …

Graves' hyperthyroidism is characterized by the presence of autoantibodies that stimulate
the thyroid-stimulating hormone receptor (TSHR), resulting in uncontrolled secretion of …

Radioiodine, antithyroid drugs and surgery have been well established therapies for Graves'
hyperthyroidism for several decades. However there remain large variations in practice …

Although medication for Graves' hyperthyroidism can be withdrawn without adverse effects
for the patient, the data regarding the optimal duration of therapy are still unsatisfactory. This …

Background: The treatment efficacy of antithyroid drug (ATD) therapy, radioactive iodine
(131I), or surgery for Graves' hyperthyroidism is well described. However, there are a few …

Graves' disease (GD) is the most common cause of hyperthyroidism worldwide. Current
therapeutic options for GD include antithyroid drugs (ATD), radioactive iodine, and …

Currently there are three well-established treatment options for hyperthyroid Graves' disease
(GD): antithyroid drug therapy with thionamides (ATD), radioactive iodine treatment with …

Background: The optimum therapy for Graves' disease (GD) is chosen following discussion
between physician and patient regarding benefits, drawbacks, potential side effects, and …